In operation since 1975, GSK’s manufacturing site in Cork produces the active ingredients for 9 of GSK’s medicines, including treatments for cancer, depression and Parkinson’s disease.
The hallmark of the Cork facility is their technical brilliance in science, engineering, production and IS systems. Cork was one of the first sites in the GSK network to co-locate an R&D plant on-site and this has continued with the creation of a ‘second generation’ facility on-site. The diversification into manufacturing consumer healthcare ingredients in 2013 is a great example of how this site adapts and innovates.
Collection of data for ATEX asset register, building ATEX Certificate Registers, inspecting in accordance with 60079 series of standards, ET:105 & ET101 National Rules.
AVS’s Technical Adviser ensured that skilled personnel were familiar with;
AVS completed a gap analysis and documentation review which included;
a) Zone classification of areas;
b) Equipment Group;
c) Temperature class requirements;
d) Equipment Characteristics;
f) Previous Inspections
Place: Currabinny, Cork